Jefferies Group’s Immunomedics Inc IMMU Stock Holding History

Jefferies Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-85,000	Closed	-$7.23M	–	1934
2020 Q3	$7.23M	Buy	+85,000	New	+$4.3M	0.08%	212
2018 Q3	–	Sell	-60,000	Closed	-$1.42M	–	2878
2018 Q2	$1.42M	Buy	+60,000	New	+$1.21M	0.01%	1072
2016 Q3	–	Sell	-1,200	Closed	-$3K	–	2554
2016 Q2	$3K	Buy	+1,200	New	+$4.01K	﹤0.01%	2082

Jefferies Group's IMMU Position: Q4 2020 in Review

Jefferies Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 160,160 shares — an estimated $13.6M sold.

Jefferies Group first reported a position in IMMU in Q2 2016 and held it in 5 quarters. The position peaked at $13.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Jefferies Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Jefferies Group sold 160,160 Immunomedics Inc shares in Q4 2020, an estimated $13.6M.
Jefferies Group first reported a position in Immunomedics Inc in Q2 2016 and held it in 5 quarters.
Jefferies Group's Immunomedics Inc position peaked at $13.6M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Jefferies Group's 13F filing for Q4 2020, filed 16 Feb 2021.